Skip to main content
HeartCited

L-Arginine for Heart Failure

D Early Research Only preliminary research exists (lab studies, case reports).

Small studies show improved exercise capacity. However, safety concerns from the VINTAGE MI trial apply to the broader acute cardiac population. Use with caution.

<\/script>\n
`; }, get iframeSnippet() { const domain = 'heartcited.com'; const params = 'ingredient\u003Dl\u002Darginine\u0026condition\u003Dheart\u002Dfailure'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

D

The Bottom Line

Small studies show improved exercise capacity. However, safety concerns from the VINTAGE MI trial apply to the broader acute cardiac population. Use with caution.

Key Study Findings

Review
Role of L-Arginine in Nitric Oxide Synthesis and Health in Humans.
Dose: None vs: None Outcome: None Effect: None None

Population: Humans (general)

animal_study
Standardized root extract of Withania somnifera and Withanolide A exert moderate vasorelaxant effect in the …
Dose: NMITLI-118R (Withania somnifera standardized root extract) and Withanolide A (WA) vs: Placebo Effect: NM and WA exerted moderate vasorelaxant effect (less than ACh); augmented ACh-induced relaxation; in not_reported
In Vitro
Astaxanthin blocks preeclampsia progression by suppressing oxidative stress and inflammation.
Dose: astaxanthin vs: L-NAME-induced preeclamptic rats Outcome: oxidative stress and blood pressure Effect: reduced ROS and improved cell survival None

Population: Preeclamptic rat model and HUVECs

In Vitro 1.0 weeks
Nitric oxide modulation in protective role of antidepressants against chronic fatigue syndrome in mice.
Dose: 10 mg/kg vs: None Outcome: anxiety Effect: None p < 0.05

Population: patients with anxiety

Other 1.0 weeks
Nitric oxide modulation mediates the protective effect of trazodone in a mouse model of chronic …
Dose: None vs: None Outcome: Nitric oxide modulation mediates the protective effect of … Effect: None p<0.05

Population: None

Review
Immunonutrition.
Dose: Glutamine, omega-3, antioxidants, arginine vs: None Outcome: Immune function and clinical outcomes Effect: None None

Population: Surgical, ICU, cancer, Crohn's disease patients

Key Statistics

3

Studies

150

Participants

Mixed

D

Grade

Referenced Papers

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

Commonly Used Dosages

endothelialfunction:
3,000-6,000 mg/day
bloodpressuresupport:
6,000-10,000 mg/day divided BID-TID

Upper limit: Not formally established; GI discomfort common above 10,000 mg/day

Dosages Studied in Research

Dosage Duration Effect N
None -- Mixed --
NMITLI-118R (Withania somnifera standardized root extract) and Withanolide A (WA) -- Positive --
astaxanthin -- Positive --
10 mg/kg 1.0 weeks Positive --
None 1.0 weeks Mixed --
Glutamine, omega-3, antioxidants, arginine -- Positive --
L-arginine -- Mixed --

Best taken: On empty stomach for best absorption; divide doses throughout the day

Safety & Side Effects

Reported Side Effects

  • Gastrointestinal discomfort (nausea, diarrhea, bloating)
  • Hypotension at high doses
  • Worsening of herpes simplex (arginine promotes viral replication)
  • Potential harm in acute post-MI patients (VINTAGE MI concern)

Known Interactions

  • Antihypertensives (additive blood pressure lowering)
  • PDE5 inhibitors (sildenafil — excessive vasodilation risk)
  • Nitrates (excessive vasodilation risk)
  • Anticoagulants (may have mild antiplatelet effect)
  • Potassium-sparing diuretics (arginine may increase potassium levels)

Tolerable upper intake: Not formally established; GI discomfort common above 10,000 mg/day

Always consult your healthcare provider before starting any supplement.

Frequently Asked Questions

Does L-Arginine help with Heart Failure?
Based on 3 studies with 150 participants, there is preliminary evidence that needs more research that L-Arginine may support Heart Failure management. Our evidence grade is D (Very Early Research).
How much L-Arginine should I take for Heart Failure?
Studies have used various dosages. A commonly studied range is 3,000-6,000 mg/day. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of L-Arginine?
Reported side effects may include Gastrointestinal discomfort (nausea, diarrhea, bloating), Hypotension at high doses, Worsening of herpes simplex (arginine promotes viral replication), Potential harm in acute post-MI patients (VINTAGE MI concern). Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for L-Arginine and Heart Failure?
We rate the evidence as Grade D (Very Early Research). This rating is based on 3 peer-reviewed studies with 150 total participants. The overall direction of effect is mixed.

References

  1. [1] Guoyao Wu et al.. Adv Exp Med Biol. 2021. Role of L-Arginine in Nitric Oxide Synthesis and Health in Humans. doi:10.1007/978-3-030-74180-8_10 PubMed
  2. [2] Priya Pathak et al.. J Ethnopharmacol. 2021. Standardized root extract of Withania somnifera and Withanolide A exert moderate vasorelaxant effect in the rat aortic rings by enhancing … doi:10.1016/j.jep.2021.114296 PubMed
  3. [3] Rong-Rong Xuan et al.. Mol Med Rep. 2016. Astaxanthin blocks preeclampsia progression by suppressing oxidative stress and inflammation. doi:10.3892/mmr.2016.5569 PubMed
  4. [4] Anil Kumar et al.. Indian J Pharmacol. 2011. Nitric oxide modulation in protective role of antidepressants against chronic fatigue syndrome in mice. doi:10.4103/0253-7613.81506 PubMed
  5. [5] Anil Kumar et al.. Pharmacol Rep. 2008. Nitric oxide modulation mediates the protective effect of trazodone in a mouse model of chronic fatigue syndrome. PubMed
  6. [6] Robert F Grimble. Curr Opin Gastroenterol. 2005. Immunonutrition. doi:10.1097/01.mog.0000153360.90653.82 PubMed
  7. [7] D Scott Lind. J Nutr. 2004. Arginine and cancer. doi:10.1093/jn/134.10.2837S PubMed

FDA Disclaimer: These statements have not been evaluated by the Food and Drug Administration. The products and information on this website are not intended to diagnose, treat, cure, or prevent any disease. The evidence grades presented are based on our analysis of published peer-reviewed research and do not constitute medical advice. Always consult your healthcare provider before starting any supplement regimen.